These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 7884504)
1. Radiolabeled chimeric anti-CEA monoclonal antibody compared with the original mouse monoclonal antibody for surgically treated colorectal carcinoma. Buchegger F; Mach JP; Pèlegrin A; Gillet M; Vogel CA; Buclin T; Ryser JE; Delaloye B; Delaloye AB J Nucl Med; 1995 Mar; 36(3):420-9. PubMed ID: 7884504 [TBL] [Abstract][Full Text] [Related]
2. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754 [TBL] [Abstract][Full Text] [Related]
3. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients. Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors. Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody. Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476 [TBL] [Abstract][Full Text] [Related]
6. CaNa2EDTA for improvement of radioimmunodetection and radioimmunotherapy with 111In and 90Y-DTPA-anti-CEA MAbs in nude mice bearing human colorectal cancer. Watanabe N; Oriuchi N; Endo K; Inoue T; Kuroki M; Matsuoka Y; Tanada S; Murata H; Kim EE; Sasaki Y J Nucl Med; 2000 Feb; 41(2):337-44. PubMed ID: 10688120 [TBL] [Abstract][Full Text] [Related]
7. Differences in biodistribution of the anti-(carcinoembryonic antigen) murine monoclonal antibody CE-25, its F(ab')2 fragment and its intact mainly human chimeric form CE 4-8-13. Dependence on tumour size and amount of antibody injected. Westera G; Rülicke T; Smith A; Duewell S Cancer Immunol Immunother; 1994 Dec; 39(6):375-82. PubMed ID: 8001025 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of colorectal tumor targeting using a novel biparatopic monoclonal antibody against carcinoembryonic antigen in experimental radioimmunoguided surgery. Kim JC; Roh SA; Koo KH; Ryu JH; Hong HK; Oh SJ; Ryu JS; Kim HJ; Bodmer WF Int J Cancer; 2002 Feb; 97(4):542-7. PubMed ID: 11802220 [TBL] [Abstract][Full Text] [Related]
9. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer. Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505 [TBL] [Abstract][Full Text] [Related]
10. Applicability of carcinoembryonic antigen-specific monoclonal antibodies to radioimmunoguided surgery for human colorectal carcinoma. Kim JC; Kim WS; Ryu JS; Oh SJ; Lee DH; Koo KH; Roh SA; Kim HC; Yu CS; Kang GH; Bodmer WF Cancer Res; 2000 Sep; 60(17):4825-9. PubMed ID: 10987293 [TBL] [Abstract][Full Text] [Related]
11. Fully human IgG and IgM antibodies directed against the carcinoembryonic antigen (CEA) Gold 4 epitope and designed for radioimmunotherapy (RIT) of colorectal cancers. Garambois V; Glaussel F; Foulquier E; Ychou M; Pugnière M; Luo RX; Bezabeh B; Pèlegrin A BMC Cancer; 2004 Oct; 4():75. PubMed ID: 15488142 [TBL] [Abstract][Full Text] [Related]
12. Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass. Williams LE; Bares RB; Fass J; Hauptmann S; Schumpelick V; Buell U Eur J Nucl Med; 1993 Apr; 20(4):345-7. PubMed ID: 8491228 [TBL] [Abstract][Full Text] [Related]
13. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibodies]. Murayama H; Watanabe T; Sakamoto J; Tadokoro M; Takagi H; Sakuma S Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1732-41. PubMed ID: 2594001 [TBL] [Abstract][Full Text] [Related]
14. Numerical selection of optimal tumor imaging agents with application to engineered antibodies. Williams LE; Wu AM; Yazaki PJ; Liu A; Raubitschek AA; Shively JE; Wong JY Cancer Biother Radiopharm; 2001 Feb; 16(1):25-35. PubMed ID: 11279795 [TBL] [Abstract][Full Text] [Related]
15. [Radioimmunodetection of 188Re-labeled anti-carcinoembryonic antigen chimeric antibody in nude mice bearing human colon carcinoma]. Zhao ZG; Ran YL; Zheng R; Kong J; Chen SZ; Yu L; Yang ZH Ai Zheng; 2002 May; 21(5):460-3. PubMed ID: 12452032 [TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy with 99mTc-labelled anti-CEA monoclonal antibody in colorectal carcinoma. Vieira MR; Rodrigues M; Salgado L; Santos R; de Almeida JC; Manoel LO; de Almeida JM Eur J Surg Oncol; 1993 Jun; 19(3):294-9. PubMed ID: 8314389 [TBL] [Abstract][Full Text] [Related]
17. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody. Pietersz GA; Patrick MR; Chester KA J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738 [TBL] [Abstract][Full Text] [Related]
18. Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody. Lee FT; Hall C; Rigopoulos A; Zweit J; Pathmaraj K; O'Keefe GJ; Smyth FE; Welt S; Old LJ; Scott AM J Nucl Med; 2001 May; 42(5):764-9. PubMed ID: 11337573 [TBL] [Abstract][Full Text] [Related]
19. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA102: experience of 20 cases]. Murakami K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Wada K; Sakuma S; Takagi H Nihon Geka Gakkai Zasshi; 1993 Feb; 94(2):119-27. PubMed ID: 8464409 [TBL] [Abstract][Full Text] [Related]
20. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein. Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]